TrialJCO global oncology2021

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience.

Amit Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.